Literature DB >> 8756629

C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter.

M Oelgeschläger1, I Nuchprayoon, B Lüscher, A D Friedman.   

Abstract

The murine neutrophil elastase (NE) gene is expressed specifically in immature myeloid cells. A 91-bp NE promoter region contains three cis elements which are conserved evolutionarily and are essential for activation of the promoter in differentiating 32D cl3 myeloid cells. These elements bound c-Myb (at -49), C/EBPalpha (at -57), and PU.1 (at -82). In NIH 3T3 cells, the NE promoter was activated by c-Myb, C/EBPalpha, and PU.1, via their respective binding sites. Cooperative activation was seen by any combination of c-Myb, C/EBPalpha, and PU.1, including all three together, again via their DNA-binding sites. In CV-1 cells, but not in NIH 3T3 cells, cooperation between Myb and C/EBPalpha depended on the integrity of the PU.1-binding site. In addition to C/EBPalpha, C/EBPdelta strongly activated the NE promoter, alone or with c-Myb, but C/EBPbeta was less active. Either of C/EBPalpha's two transactivation domains cooperatively activated the promoter with c-Myb, in both NIH 3T3 and 32D c13 cells. Synergistic binding to DNA in a gel shift assay between C/EBPalpha, c-Myb, and PU.1 could not be demonstrated. Also, separation of the C/EBP- and c-Myb-binding sites by 5 or 10 bp did not prevent cooperativity. These results suggest that a coactivator protein mediates cooperative activation of the NE promoter by a C/EBP and c-Myb. These factors, together with PU.1, direct restricted expression of the NE promoter to immature myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756629      PMCID: PMC231472          DOI: 10.1128/MCB.16.9.4717

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Structure of the human neutrophil elastase gene.

Authors:  H Takahashi; T Nukiwa; K Yoshimura; C D Quick; D J States; M D Holmes; J Whang-Peng; T Knutsen; R G Crystal
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

2.  The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite.

Authors:  W H Landschulz; P F Johnson; S L McKnight
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

3.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

4.  A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content.

Authors:  N L Warner; M A Moore; D Metcalf
Journal:  J Natl Cancer Inst       Date:  1969-10       Impact factor: 13.506

5.  Identification of two polypeptide segments of CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin gene.

Authors:  A D Friedman; S L McKnight
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

6.  CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells.

Authors:  A D Friedman; W H Landschulz; S L McKnight
Journal:  Genes Dev       Date:  1989-09       Impact factor: 11.361

7.  Myelomonocytic cell lineage expression of the neutrophil elastase gene.

Authors:  H Takahashi; T Nukiwa; P Basset; R G Crystal
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

Review 8.  CCAAT-enhancer binding protein: a component of a differentiation switch.

Authors:  R M Umek; A D Friedman; S L McKnight
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

9.  CBP as a transcriptional coactivator of c-Myb.

Authors:  P Dai; H Akimaru; Y Tanaka; D X Hou; T Yasukawa; C Kanei-Ishii; T Takahashi; S Ishii
Journal:  Genes Dev       Date:  1996-03-01       Impact factor: 11.361

10.  Expression of the neutrophil elastase gene during human bone marrow cell differentiation.

Authors:  P Fouret; R M du Bois; J F Bernaudin; H Takahashi; V J Ferrans; R G Crystal
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  56 in total

1.  Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb.

Authors:  M Britos-Bray; A D Friedman
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis.

Authors:  Li Chai
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

3.  v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter.

Authors:  Olesya Chayka; Jörg Kintscher; Daniel Braas; Karl-Heinz Klempnauer
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  Essential requirement of CCAAT/enhancer binding proteins in embryogenesis.

Authors:  Valérie Bégay; Jeske Smink; Achim Leutz
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

5.  Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.

Authors:  S Ethelberg; J Lovmand; J Schmidt; A Luz; F S Pedersen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 6.  The interferon signaling network and transcription factor C/EBP-beta.

Authors:  Hui Li; Padmaja Gade; Weihua Xiao; Dhan V Kalvakolanu
Journal:  Cell Mol Immunol       Date:  2007-12       Impact factor: 11.530

7.  C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.

Authors:  Julia E Dooher; Ido Paz-Priel; Simone Houng; Albert S Baldwin; Alan D Friedman
Journal:  Mol Cancer Res       Date:  2011-08-03       Impact factor: 5.852

8.  Distinct C/EBP functions are required for eosinophil lineage commitment and maturation.

Authors:  C Nerlov; K M McNagny; G Döderlein; E Kowenz-Leutz; T Graf
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

9.  Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1.

Authors:  M S Petrovick; S W Hiebert; A D Friedman; C J Hetherington; D G Tenen; D E Zhang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

10.  High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.

Authors:  Ji Suk Chang; Ramasamy Santhanam; Rossana Trotta; Paolo Neviani; Anna M Eiring; Edward Briercheck; Mattia Ronchetti; Denis C Roy; Bruno Calabretta; Michael A Caligiuri; Danilo Perrotti
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.